Invention Grant
- Patent Title: Thiol-modified hyaluronan
-
Application No.: US10640815Application Date: 2003-08-14
-
Publication No.: US06884788B2Publication Date: 2005-04-26
- Inventor: Paul C. A. Bulpitt , Charles H. Sherwood , Khalid K. Sadozai
- Applicant: Paul C. A. Bulpitt , Charles H. Sherwood , Khalid K. Sadozai
- Applicant Address: US MA Woburn
- Assignee: Anika Therapeutics, Inc.
- Current Assignee: Anika Therapeutics, Inc.
- Current Assignee Address: US MA Woburn
- Agency: Hamilton, Brook, Smith & Reynolds, P.C.
- Main IPC: A61K31/728
- IPC: A61K31/728 ; A61P27/02 ; A61P41/00 ; C07C323/25 ; C07C323/32 ; C07C323/37 ; C07C323/44 ; C07C323/45 ; C07C335/08 ; C07C335/16 ; C08B37/08 ; C08B37/00

Abstract:
The present invention relates to biscarbodiimides, thiourea derivatives, urea derivatives, and cross-linked hyaluronan derivatives having at least one intramolecular disulfide bond, and methods of preparation thereof. The invention also includes thiolated hyaluronan derivatives and salts thereof having at least one pendant thiol group or a modified pendant thiol group, and methods of preparation thereof. An example of a modified pendant thiol group is a sulfhydryl group linked to a small molecule such as a bioactive agent, for example a drug or pharmaceutically active moiety. A hyaluronan derivative having a sulfhydryl group linked to a pharmaceutically active moiety is useful as a sustained or controlled release drug delivery vehicle. Compositions containing the hyaluronan derivatives of the invention can reversibly viscosify in vivo or in vitro, in response to mild changes in condition, and are thus useful in ophthalmic surgery and in tissue engineering.
Public/Granted literature
- US20040038934A1 Thiol-modified hyaluronan Public/Granted day:2004-02-26
Information query
IPC分类: